Published in Lab Business Week, October 28th, 2007
Preliminary in vitro animal study tests performed by two separate independent laboratories, using the company's ABL SilverSol Technology at 10 parts per million against two strains of the H5-N1 subtype of the Avian Bird Flu virus, indicated that the ABL products were able to neutralize the virus.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week